Phenotypic variation in hereditary frontotemporal dementia with tau mutations

Several mutations in the tau gene have been found in families with hereditary frontotemporal dementia and parkinsonism linked to chromosome 17q21‐22 (FTDP‐17). This study is the first attempt to correlate genotype and phenotype in six families with FTDP‐17 with mutations in the tau gene (ΔK280, G272V, P301L, and R406W). We have investigated tau pathology in 1 P301L and 1 R406W patient. The R406W family showed a significantly higher age at onset (59.2 ± 5.5 years) and longer duration of illness (12.7 ± 1.5 years) than the families with the other mutations. The six families showed considerable variation in clinical presentation, but none of them had early parkinsonism. Mutism developed significantly later in the R406W family than in the other families. Frontotemporal atrophy on neuroimaging in the R406W family was less severe than in the P301L and ΔK280 families. The P301L brain contained many pretangles in the frontal and temporal cortex, and the dentate gyrus of hippocampus, showing three tau bands (64, 68, and 72 kd) of extracted tau from the frontal cortex. The presence of many neurofibrillary tangles, many diffuse and classic neuritic plaques in the temporal and parietal cortex, and the hippocampus of the same P301L brain correlated with the presence of four sarkosyl‐insoluble (60, 64, 68, and 72 kd) tau bands. The coexistence of characteristic P301L and Alzheimer pathology in the same brain needs further explanation. The R406W brain showed abundant neurofibrillary tangles in several brain regions, and four tau bands (60, 64, 68, and 72 kd) of extracted tau from these regions. The slower progression of the disease in the R406W family might be explained by the microtubule‐binding properties of the mutant protein.

[1]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R A Crowther,et al.  Tau pathology in a family with dementia and a P301L mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[3]  D. Dickson,et al.  Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.

[4]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[5]  S. Lovestone,et al.  Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation , 1999, FEBS letters.

[6]  J. Morris,et al.  Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations , 1999, Neuroscience Letters.

[7]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[8]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[9]  W. Kamphorst,et al.  Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. , 1998, The American journal of pathology.

[10]  R. Crowther,et al.  Tau Mutations Cause Frontotemporal Dementias , 1998, Neuron.

[11]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[13]  Y. Agid,et al.  Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. , 1998, Human molecular genetics.

[14]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[16]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[17]  N. Craddock,et al.  Hereditary dysphasic disinhibition dementia A frontotemporal dementia linked to 17 q21‐‐22 , 1998, Neurology.

[18]  P. Scheltens,et al.  Familial aggregation in frontotemporal dementia , 1998, Neurology.

[19]  J. Trojanowski,et al.  The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”) , 1998, Journal of neuropathology and experimental neurology.

[20]  B. Ghetti,et al.  Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies , 1998, Brain pathology.

[21]  M. Farrer,et al.  Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21–22 , 1997, Annals of neurology.

[22]  M. L. Schmidt,et al.  Autosomal dominant dementia with widespread neurofibrillary tangles , 1997, Annals of neurology.

[23]  L. Lannfelt,et al.  Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. , 1997, American journal of medical genetics.

[24]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[25]  R A Crowther,et al.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Heutink,et al.  Hereditary frontotemporal dementia is linked to chromosome 17q21—q22: A genetic and clinicopathological study of three dutch families , 1997, Annals of neurology.

[27]  F. Dark.  A Family with Autosomal Dominant, Non-Alzheimer's Presenile Dementia , 1997, The Australian and New Zealand journal of psychiatry.

[28]  F Barkhof,et al.  Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.

[29]  R. Crowther,et al.  Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.

[30]  R. Defendini,et al.  The neuropathology of chromosome 17‐linked dementia , 1996, Annals of neurology.

[31]  W. Markesbery,et al.  Familial progressive subcortical gliosis , 1995, Neurology.

[32]  K. Marder,et al.  Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex , 1994, Neurology.

[33]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[34]  S. M. Sumi,et al.  Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala , 1992, Neurology.

[35]  J. Pastor,et al.  Blood groups of the Cantabrian population (Spain). , 1992, Human heredity.

[36]  R. Crowther.  Straight and paired helical filaments in Alzheimer disease have a common structural unit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[38]  J. Groen,et al.  HEREDITARY PICK'S DISEASE , 1982 .

[39]  V. W. Schenk.  RE‐EXAMINATION OF A FAMILY WITH PICK'S DISEASE , 1959, Annals of human genetics.